Rs28371725

From SNPedia
Jump to: navigation, search

is asnp
is mentioned by
dbSNPrs28371725
nextbiors28371725
hapmaprs28371725
1000 genomesrs28371725
hgdprs28371725
ensemblrs28371725
gopubmedrs28371725
scholarrs28371725
googlers28371725
pharmgkbrs28371725
gwascentralrs28371725
openSNPrs28371725
23andMers28371725
23andMe allrs28371725
SNP Nexus

SNPshotrs28371725
SNPdbers28371725
MSV3drs28371725
GeneCYP2D6
Chromosome22
Orientationminus
Position42523805
ReferenceGRCh37 37.1/131
Max Magnitude0
Geno Mag Summary
(A;A) CYP2D6*41 homozygote
(A;G) carrier of one CYP2D6*41 allele
(G;G) 0 normal
rs28371725, also known as 2988G>A, is a SNP in the CYP2D6 gene.

The rs28371725(A) allele defines the CYP2D6*41 variant, which has decreased activity.

23andMe also has SNP i4001476 at the same position.

PharmGKBPA162372821
NameCYP2D6:2988G>A, part of CYP2D6*41
AnnotationThis variant is part of the CYP2D6*41 IM haplotype. Plasma concentrations of metoprolol were shown to be were 4.9-fold higher in the PMs, with greater reductions in heart rate, diastolic blood pressure, and mean arterial pressure in PMs than in non-PMs.
GeneCYP2D6
FeatueIntron
EvidencePubMed ID:19037197; Web Resource:http://preview.pharmgkb.org/search/annotatedGene/cyp2d6/variant.jsp
Drugsmetoprolol
Diseases
Curation LevelCurated
PharmGKBPA161145193
NameCYP2D6*41, CYP2D6:2988G>A
AnnotationThis intronic polymorphism causes a splicing defect resulting in an activity reduction. This variant is diagnostic of the haplotype CYP2D6*41.
GeneCYP2D6
FeatueIntron
EvidenceWeb Resource:http://www.pharmgkb.org/search/annotatedGene/cyp2d6/variant.jsp#ImportantVariantInformationforCYP2D6-999
Drugs
Diseases
Curation LevelIn-Depth


[PMID 22448283] Genotyping Performance between Saliva and Blood-Derived Genomic DNAs on the DMET Array: A Comparison

Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox